Material Data Sheet

Human Pan-SUMO, MAb

Price: $229.00
Catalog #: A-714
Human Pan-SUMO, MAb
100 μg
Data Sheet: 
Small Ubiquitin-like Modifiers (SUMOs) are a family of small, related proteins that can be enzymatically attached to a target protein by a post-translational modification process termed SUMOylation. Unlike ubiquitination which targets proteins for degradation, SUMOylation participates in a number of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. All human SUMO proteins share a conserved ubiquitin-like domain and a C-terminal diglycine cleavage/attachment site. Human SUMO1, SUMO2, SUMO3, and SUMO4 are all translated as propeptides, containing C-terminal prosegments following the diglycine motif that marks the end of the mature forms. Following prosegment cleavage, SUMO1, 2, and 3 may then be enzymatically attached to a lysine on a target protein. It is not clear whether SUMO4 is processed in a similar fashion.

Product Information

0.5 mg/mL in PBS, pH 7.4, 50% glycerol, 0.09% sodium azide
IgG2A. Clone # 852721
Western Blot Data: 
Purified, recombinant human SUMO2. Accession Number P61956

Use & Storage

Recommended concentration for Western Blot is 0.1 - 0.5 µg/ml.
Store at -20°C.
This antibody detects endogenous, human SUMOylated proteins in Western blots, and has similar sensitivity when tested against purified, recombinant SUMO1, SUMO2, SUMO3 and SUMO4.



Desterro J.M., et al. (1997) FEBs. Lett. 417: 297-300

Okama T., et al. (1999) Biochem. Biophys. Res. Comm. 254: 693-698

Seeler J-S. and Dejean A. (2003) Nat. Rev. 4: 690-699

Su H-L., et al. (2002) Gene 296: 65-73

Tatham M.H., et al. (2001) J. Biol. Chem. 276: 35368-35374

Yeh E.T.H., et al. (2000) Gene 248: 1-14